The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/mhra-clears-brensocatib-bronchiectasis-2026a100062q?src=rss
Author :
Publish date : 2026-02-26 12:15:00
Copyright for syndicated content belongs to the linked Source.
